ucb sa (UCB:Euronext Brussels)
Transactions by UCB SA (UCB) in the last 6 months
Advent International Corporation and Avista Capital Holdings, L.P. signed an agreement to acquire Kremers Urban Pharmaceuticals Inc. from UCB SA (ENXTBR:UCB) for $1.5 billion in cash on November 7, 2014. The deal financing is provided by Credit Suisse Securities LLC, Morgan Stanley & Co. LLC, Goldman, Sachs & Co and Jefferies LLC. Brian Markison, a healthcare Industry Executive at Avista, will become President and Chief Executive Officer of Kremers Urban. The transaction ...
Avista Capital Holdings, L.P.
Dermira, Inc. (NasdaqGS:DERM) announced that it has entered into a common stock purchase agreement for the private placement of 468,750 shares at a price of $16 per share for gross proceeds of $7,500,000 on September 19, 2014.The company will not pay any underwriting discounts or commissions with respect to the shares. The securities will be issued to the existing investor UCB SA. The investor invested through its affiliate, UCB Pharma S.A.
|Endo International PLC||$85.60 USD||+0.36|
|Grifols SA||€36.26 EUR||-0.465|
|Hospira Inc||$87.54 USD||0.00|
|Sigma-Aldrich Corp||$138.06 USD||0.00|
|Valspar Corp/The||$86.65 USD||+0.33|
|View Industry Companies|